GlaxoSmithKline Says 5 Late-Stage Flu Trials Met Goals
GlaxoSmithKline Plc said results from five late-stage trials of two experimental quadrivalent influenza vaccines (QIV) met the main goal of protecting against mild as well as moderate-severe cases of influenza.